A Study to Test the Safety of Three Experimental HIV Vaccines

NCT00000946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
HIV Seronegativity

Interventions

BIOLOGICAL: HIV p24/MF59 Vaccine
BIOLOGICAL: ALVAC-HIV MN120TMG (vCP205)
BIOLOGICAL: ALVAC-RG Rabies Glycoprotein (vCP65)
BIOLOGICAL: rgp120/HIV-1 SF-2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)